<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01196884</url>
  </required_header>
  <id_info>
    <org_study_id>UNIT</org_study_id>
    <nct_id>NCT01196884</nct_id>
  </id_info>
  <brief_title>Immune Thrombocytopenia (ITP) Immune-Genetic Assessment</brief_title>
  <acronym>UNIT</acronym>
  <official_title>IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria-Universitaria Integrata di Udine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria-Universitaria Integrata di Udine</source>
  <brief_summary>
    <textblock>
      Primary ITP has wide heterogenous biology, presentation and response to therapy.

      The immune-genetic assessment of ITP may help to identify differences among patients with ITP
      and optimize the therapeutic choice.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Thrombocytopenia</condition>
  <arm_group>
    <arm_group_label>Asymptomatic ITP patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ITP patients treated with Rituximab</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ITP patients treated with steroids</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with primary ITP

        Exclusion Criteria:

          -  Secondary ITP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francesco Zaja, MD</last_name>
    <phone>+39 0432 559604</phone>
    <email>zaja.francesco@aoud.sanita.fvg.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituto di Ematologia L. &amp; A. Seragnoli</name>
      <address>
        <city>Bologna</city>
        <zip>40100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Vianelli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco</name>
      <address>
        <city>Cagliari</city>
        <zip>09100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilio Usala, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UF Ematologia, Policlinico di Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonella Gozzini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wilma Barcellini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Oncology/Haematology, Niguarda Ca'Granda Hospital</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Cantoni, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale &quot;Amedeo Avogadro</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianluca Gaidano, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale &quot;Amedeo Avogadro&quot;</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Medical and Surgical Sciences, University of Padova</name>
      <address>
        <city>Padova</city>
        <zip>35100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrizio Fabris, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology-Hematology Department, &quot;S. Maria delle Croci&quot; Hospital</name>
      <address>
        <city>Ravenna</city>
        <zip>48121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alfonso Zaccaria, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Hematology, Catholic University,</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerio De Stefano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia, Ospedale Ca' Foncello</name>
      <address>
        <city>Treviso</city>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Filippo Gherlinzoni, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Ematologica AOUD S. Maria Misericordia</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Zaja, MD</last_name>
      <phone>+39 0432559604</phone>
      <email>zaja.francesco@aoud.sanita.fvg.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Zaja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ematologia, San Bortolo Hospital</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Rodeghiero, Prof.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <name_title>Francesco Zaja</name_title>
    <organization>Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine</organization>
  </responsible_party>
  <keyword>Patients with primary Immune Thrombocytopenia (ITP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombocytopenia</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic, Idiopathic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

